CyberKnife System
Device
Accuray Incorporated
Total Payments
$2.3M
Transactions
1,445
Doctors
365
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $126,781 | 165 | 72 |
| 2023 | $124,659 | 103 | 43 |
| 2022 | $389,926 | 316 | 67 |
| 2021 | $199,835 | 96 | 43 |
| 2020 | $156,583 | 84 | 36 |
| 2019 | $223,795 | 172 | 73 |
| 2018 | $460,488 | 258 | 92 |
| 2017 | $626,182 | 251 | 110 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $870,013 | 76 | 37.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500,818 | 232 | 21.7% |
| Travel and Lodging | $257,886 | 250 | 11.2% |
| Honoraria | $210,684 | 94 | 9.1% |
| Grant | $205,000 | 3 | 8.9% |
| Consulting Fee | $154,340 | 67 | 6.7% |
| Food and Beverage | $54,769 | 716 | 2.4% |
| Education | $54,330 | 5 | 2.4% |
| Royalty or License | $317.34 | 1 | 0.0% |
| Entertainment | $91.33 | 1 | 0.0% |
Payments by Type
General
$1.4M
1,369 transactions
Research
$870,013
76 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Joint Lung Cancer Trialist's Coalition, JoLT - Ca | Accuray Incorporated | $137,500 | 0 |
| Phase I trial of Single Franction Stereotactic Partial Breast Irradiation on the CyberKnife (S-PBI) | Accuray Incorporated | $105,000 | 0 |
| Joint Lung Cancer Trialist's Coalition, JoLT - Ca | ACCURAY INCORPORATED | $100,000 | 0 |
| Prospective Evaluation of CyberKnife Radiosurgery for Low and Intermediate Risk Prostate Cancer: Homogenous Dose Distribution | Accuray Incorporated | $83,903 | 0 |
| 4x projects investigating Breast and Prostate Cancer with CyberKnife | Accuray Incorporated | $80,000 | 0 |
| Phase I Trial of Single Fraction Stereotactic Partial Breast Irradiation on the CyberKnife (S-PBI) | Accuray Incorporated | $70,000 | 0 |
| A Pilot Study of Stereotactic Radiosurgery combined with Ipilimumab in Patients with Newly Diagnosed Melanoma Metastases in the Brain and Spine | Accuray Incorporated | $58,000 | 0 |
| Outcome parameters of SBRT treatment for Breast Cancer | Accuray Incorporated | $50,000 | 0 |
| Prospective Evaluation of CyberKnife Radiosurgery for Low and Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry | Accuray Incorporated | $36,000 | 0 |
| A Retrospective Study to Describe Clinical Course after Radiosurgery for Brain Metastasis | Accuray Incorporated | $34,495 | 0 |
| Breast APBI and Prostate SBRT with CyberKnife | ACCURAY INCORPORATED | $30,000 | 0 |
| International Randomized Study of Laparoscopic Prostatectomy vs. Robotic Radiosurgery and Conventionally Fractionated Radiotherapy vs. Radiosurgery for Early Stage Organ-Confined Prostate Cancer | Accuray Incorporated | $19,250 | 0 |
| Auto prostate planning | Accuray Incorporated | $14,571 | 0 |
| MP5.0 User Evaluation | Accuray Incorporated | $14,571 | 0 |
| Unnamed | Accuray Incorporated | $7,106 | 0 |
| Multi Leaf Collimator 2 Treatment Planning System Studies | Accuray Incorporated | $6,946 | 0 |
| A Phase I Study of CyberKnife Partial Breast Irradiation (PBI) for Early Stage Breast Cancer | Accuray Incorporated | $6,500 | 0 |
| Prospective Evaluation of CyberKnife Radiosurgery for low and Intermediate Risk Prostate Cancer: Homogenous Dose Distribution | Accuray Incorporated | $6,300 | 0 |
| Prospective Evaluation of CyberKnife Radiosurgery for Low and Intermediate Risk Prostate Cancer: Homogeonous Dose Distribution | Accuray Incorporated | $6,200 | 0 |
| Prospective Evaluation of Cyberknife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry | Accuray Incorporated | $2,670 | 0 |
Top Doctors Receiving Payments for CyberKnife System — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Radiation Oncology | Memphis, TN | $12,264 | 14 |
| , M.D | Internal Medicine | Aurora, CO | $12,007 | 6 |
| , MBBS | Radiation Oncology | Danville, PA | $11,933 | 19 |
| , D.O | Radiation Oncology | Cleveland, OH | $11,757 | 9 |
| , MD | Neurological Surgery | Stanford, CA | $11,005 | 2 |
| , M.D | Radiation Oncology | Providence, RI | $9,515 | 2 |
| , MD | Radiation Oncology | Pittsburgh, PA | $8,946 | 4 |
| , MD | Radiation Oncology | Stanford, CA | $8,833 | 10 |
| , MD | Internal Medicine | Novi, MI | $7,505 | 8 |
| , M.D | Radiation Oncology | Pennington, NJ | $6,462 | 3 |
| , M.D | Radiation Oncology | New York, NY | $5,413 | 7 |
| , MD | Radiation Oncology | Baltimore, MD | $5,211 | 10 |
| , M.D | Radiation Oncology | San Francisco, CA | $5,110 | 2 |
| Cullen Taniguchi | — | Houston, TX | $4,620 | 7 |
| , MD | Therapeutic Radiology | Cape Coral, FL | $4,512 | 4 |
| , M.D | Neurological Surgery | Stanford, CA | $4,141 | 2 |
| , M.D | Radiation Oncology | Dublin, CA | $3,777 | 10 |
| , MD | Radiation Oncology | Drexel Hill, PA | $3,422 | 2 |
| , M.D | Medical Oncology | Fairfax, VA | $3,263 | 6 |
| , MD, PHD | Neurological Surgery | Stanford, CA | $3,258 | 5 |
| , MD | Radiation Oncology | Mineola, NY | $3,210 | 9 |
| , MD | Neurological Surgery | Palo Alto, CA | $3,044 | 4 |
| , M.D | Radiation Oncology | Montgomery, OH | $2,784 | 7 |
| , M.D | Radiation Oncology | Grand Forks, ND | $2,762 | 9 |
| , M.D | Radiation Oncology | Seattle, WA | $2,640 | 1 |
Ad
Manufacturing Companies
- Accuray Incorporated $1.9M
- ACCURAY INCORPORATED $387,417
Product Information
- Type Device
- Total Payments $2.3M
- Total Doctors 365
- Transactions 1,445
About CyberKnife System
CyberKnife System is a device associated with $2.3M in payments to 365 healthcare providers, recorded across 1,445 transactions in the CMS Open Payments database. The primary manufacturer is Accuray Incorporated.
Payment data is available from 2017 to 2024. In 2024, $126,781 was paid across 165 transactions to 72 doctors.
The most common payment nature for CyberKnife System is "Unspecified" ($870,013, 37.7% of total).
CyberKnife System is associated with 20 research studies, including "Joint Lung Cancer Trialist's Coalition, JoLT - Ca" ($137,500).